We have developed a multiplex reporter system to monitor multiple biological variables in real-time. The secreted Gaussia luciferase was fused to ten different epitope tags (Gluc tag ), each expressed in different tumor cells. By immunobinding of the tags followed by Gluc tag detection, this system allowed the independent and real-time monitoring of mixed cell cultures in vitro and of mixed subcutaneous and intracranial tumor subpopulations in vivo.
T o study complex processes in systems biology, tools are needed that give insight into multiple molecular and cellular interactions simultaneously and in real-time 1, 2 . Several cellular reporter systems are in use to shed light on biological processes, many based on luciferase enzymes and their photon production upon luciferin substrate addition, including Firefly luciferase (Fluc) 3 , Renilla luciferase (Rluc) 4 , and Gaussia luciferase (Gluc) 5, 6 . These bioluminescent reporters have been used to monitor biological processes such as cellular proliferation and differentiation 7 , transcription factor activity 8 , translational repression by miRNA 9, 10 , and intercellular interactions 11 , reviewed in 12 . Other commonly used reporters are based on the green fluorescent protein (GFP), the red fluorescent protein (RFP) and, more recently, near infra-red fluorescent proteins 13, 14 which can be multiplexed together to monitor several processes simultaneously using spectral unmixing in conjunction with fluorescence molecular tomography 15 . These reporters have several disadvantages including low sensitivity due to autofluorescence, complexity, and the requirement of expensive instrumentation. Further, similar to bioluminescence, limited numbers of variables can be monitored simultaneously, limiting their use in multiplex screening assays and cellular heterogeneity studies. Here, we developed a multiplex bioluminescence assay that allows monitoring of many variables in real-time within the same biological system. This assay is based on Gluc since this reporter is highly sensitive, naturally secreted, and can be detected in the conditioned medium of cells in culture as well as in the blood of animals ex vivo, allowing real-time monitoring of cellular variables 5, 6 .
Results
We constructed a library of lentiviral vectors consisting of the Gluc cDNA fused to ten different epitope tags at its C-terminus, under the constitutively active cytomegalovirus (CMV) promoter resulting in Gluc Flag , Gluc His , Gluc HA , Gluc AcV5 , Gluc V5 , Gluc Glu , Gluc Myc , Gluc Kt3 , Gluc Au1 , Gluc E2 , and the control reporter construct without tag, Gluc Ctrl . These lentiviral vectors also express cerulean fluorescent protein (CFP) separated from Gluc tag by an internal ribosomal entry site (IRES) element as a marker for transduction efficiency ( Fig. 1a and Methods section). We employed human U87 glioblastoma cells stably expressing Fluc and the mCherry fluorescent protein 6 (U87-FM) for validation of the Gluc tag multiplex system. These cells were transduced with each of the lentiviral vectors to produce ten different cell lines, each stably expressing a different Gluc tag and CFP (U87-FM-Gluc tag -CFP). Fluorescent microscopy analysis for mCherry and CFP showed that these cells were nearly 100% transduced with the reporter vectors ( Fig. 1b ). We first demonstrated that all of the individual U87-FM-Gluc tag -CFP cells expressed the corresponding tags by immunostaining using specific antibodies, except for Gluc Au1 that was not detectable by immunostaining attributed to anti-Au1 antibody properties ( Fig. 1c ). As a control we stained cells expressing Gluc ctrl with the different tag antibodies, which did not show any staining (data not shown). We confirmed Gluc tag expression by Western blot using anti-tag antibodies (Sup. Fig. 1a ) and RT-PCR of the tag region (Sup. Fig. 1b and c). Next, we determined the effect of the tags on Gluc by measuring luciferase activity at different time points in an aliquot of conditioned medium from U87-FM cells expressing each Gluc tag reporter construct using the Gluc substrate coelenterazine. We demonstrated that fusion of epitope tags to Gluc does not dramatically affect the expression, secretion or activity of Gluc ( Fig. 1d and supplemental Fig. 1a -c). We then used the conditioned media containing the different Gluc tag constructs to optimize antibody-tag immunobinding in a 96-well plate format (Methods).
Plates were first coated with monoclonal antibodies against the different tags and incubated with different amounts of conditioned medium allowing Gluc tag immunobinding. Subsequently, the wells were washed to remove unbound Gluc tag and subjected to the Gluc assay by direct addition of coelenterazine to the wells and measuring photon counts using a plate luminometer. As a control, an aliquot of total Gluc tag activity in the blood (red), and bound Gluc tag activity after immunobinding (blue). (c-d) U87-FM cells expressing the different Gluc tag reporters were mixed in equal amounts and injected subcutaneously in the same mouse (n55). Tumor growth was monitored using Fluc imaging and total Gluc blood assay as in (a-b). Individual cells subpopulation within the same tumor were monitored using the multiplex Gluc tag immunobinding assay. (e) Immunostaining for the ten different tags expression in the mixed U87-FM-Gluc tag -CFP tumor. Black arrows indicate positive staining for cells expressing the corresponding Gluc tag . Size bar 5 200 mm. N.d. 5 not detectable. (f-g) Mixed population of U87-FM cells expressing all ten different tags were implanted intracranially in the brain of nude mice (n55). Tumor growth was monitored with Fluc imaging and Gluc total blood assay, and different tumor cell subpopulations were monitored using the multiplex Gluc tag assay as in (c-d). Fluc bioluminescence imaging of a representative mouse is shown in (f). Data shown in (b,d, and g) as average relative light units (RLU) 6 standard deviation. Heatscales in (a, c and f) indicate relative photon levels (photons/sec) as measured by the CCD camera. conditioned medium was assayed directly for total Gluc activity. We determined that six of the ten individual Gluc tag constructs, i.e. Gluc Flag , Gluc His , Gluc HA , Gluc AcV5 , Gluc V5 , Gluc Glu , reported with high-efficiency after immunobinding in the antibody-coated wells, as compared to total Gluc tag activity (Fig. 1e ). The Gluc Myc , Gluc Kt3 , Gluc Au1 , and Gluc E2 reporters showed lower activity upon immunobinding, attributed to suboptimal antibody-tag interactions. In order to demonstrate the use of the Gluc tag system for multiplex applications, we mixed equal numbers of the ten different U87-FM-Gluc tag -CFP cells and plated them in a single well. One, three and five days later, we measured the total Gluc level in aliquots of the conditioned medium. The levels of the individual Gluc tag reporters in the mixed culture medium were analyzed by immunobinding with the different tag specific antibodies. We were able to monitor in real-time the growth of the individual U87-FM-Gluc tag -CFP cell populations in the mixed culture ( Fig. 1f ). Immunostaining confirmed the expression of each tag in the corresponding cells in the mixed culture, again except for Gluc Au1 (Fig. 1g ). In order to determine whether we can measure the activity of ten different Gluc tag constructs in the same cell, we transduced U87-FM cells with all ten different lentiviral gluc tag reporters. Immunostaining of the U87-FM-Gluc 103 tag CFP glioblastoma cells with tag specific antibodies showed that almost all cells expressed all ten different Gluc tag constructs (Fig. 1h ). The tag expression as demonstrated by immunostaining is less intens in Fig. 1h as compared to Fig. 1c , which we attribute to the transduction pool of ten different lentivectors used in Fig. 1h . We used these cells to monitor cell viability in the presence and absence of the alkylating agent temozolomide (TMZ), the standard chemotherapy for glioblastoma patients. Gluc tag immunobinding assays were used to determine the expression of all ten reporters in the presence or absence of TMZ. We treated the U87-FM-Gluc 10 3 tag CFP cells with TMZ and measured Gluc tag activity after six days (Fig. 1i ). Precipitation of all ten different Gluc tag reporters showed a ,75% decrease in Gluc bioluminescence signal after TMZ treatment, similar to the total Gluc signal and confirmed by CFP immunofluorescence analysis (Fig. 1j ). Altogether, these results demonstrate that we can measure biologically relevant differences using our multiplex Gluc tag system.
In order to determine the in vivo applicability of the Gluc tag reporter assay, we injected the ten individual U87-FM cell cultures expressing either one of the Gluc tag or Gluc Ctrl reporters subcutaneously in nude mice for singleplex application. In another set, we injected mice with PBS as a negative control (12 groups; n53/group). Tumor growth was monitored over time by calliper measurement, and Fluc bioluminescence imaging ( Fig. 2a,b ). Blood was collected from mice at different time points and 5 ml of whole blood (optimum amount for Gluc blood assay 16 ) was assayed for total Gluc activity. At the same time, 25 ml of blood was analyzed for Gluc activity after immunobinding on wells coated with the corresponding tag antibody ( Fig. 2b) . All of the Gluc tag reporters, except Gluc E2 , allowed blood monitoring of tumor growth over time in a singleplex assay. We compared the tumor growth as measured by calliper, Fluc imaging and Gluc blood assay to signals obtained from the ten different Gluc tag reporters after immunobinding (Fig. 2b) . The six Gluc tag reporters Gluc Flag , Gluc His , Gluc HA , Gluc AcV5 , Gluc V5 , Gluc Glu were more sensitive in detecting tumor growth than the others, possibly due to a higher affinity of the antibodies to these tags. To demonstrate the use of the Gluc tag system for multiplex applications, we mixed equal numbers of U87-FM cells expressing the ten different Gluc tag and implanted the heterogeneous cell pool subcutaneously in nude mice (n55). We monitored tumor growth by Fluc bioluminescence imaging and total Gluc blood assay (Fig. 2c,d ). Importantly, we were able to efficiently monitor the growth of the individual subpopulation of the U87-FM cells expressing the different high-efficiency Gluc tag reporters (Gluc Flag , Gluc His , Gluc HA , Gluc AcV5 , Gluc V5 , Gluc Glu ) in the same tumor over time (Fig. 2d) . We confirmed the expression of all tags (except for Gluc Au1 ) in the same tumor by immunostaining ( Fig. 2e ). To determine the applicability of the Gluc tag multiplex system in deep tissues, the mixture of the ten different U87-FM-Gluc tag -CFP cells were implanted orthotopically in the brain of nude mice (n55). We monitored tumor growth by Fluc bioluminescence imaging and total Gluc blood assay (Fig. 2f,g ). Again, we were able to monitor the intracranial growth of the individual subpopulations of U87-FM cells expressing the high-efficiency Gluc tag reporters within the same brain tumor in real-time, by blood sampling and the application of the Gluc tag multiplex reporter system (Fig. 2g ).
Discussion
Here we demonstrated the functionality of the Gluc tag multiplex reporter system by the parallel monitoring of mixed cell cultures in vitro, and of subpopulations in mixed subcutaneous and intracranial tumors ex vivo. The individual epitope tags could also be employed to localize expression by immunostaining. We used ten different Gluc tag reporters, but this tag library can be readily extended allowing for increased multiplexing. In addition, antibody binding of the lowefficiency tags in the Gluc tag immunobinding assay might be further optimized to achieve higher sensitivity since these tags, except for Gluc AU1 , were efficiently detected by immunostaining. Real-time monitoring of individual cells in a heterogeneous mixture may allow, for instance, multiplexed RNAi screening or measurement of drug responses of multiple cell populations in parallel. The Gluc tag multiplex system might be extended to monitor different variables in a single cell type. For instance, engineering each individual Gluc tag under the control of different transcription response elements for multiplex transcription factor activity measurements 7 , constructing microRNA (miRNA)-binding sequences in the 39-UTR of the Gluc tag constructs for multiplex monitoring of miRNA activity 10 or by inserting different protease cleavage sites into the Gluc tag gene for multiplex protease activity measurement 17 . This reporter assay provides a versatile tool to study complex processes with different variables in systems biology.
Methods
Cells. For in vitro and in vivo validation, we used the glioblastoma cell line U87, stably co-expressing Firefly luciferase and mCherry fluorescent protein. Cell lines were maintained in DMEM high glucose complemented with sodium pyruvate, stable glutamine, 10% FBS and pen/strep (all PAA), incubated under standard cell culture conditions of 37uC and 5% CO 2 .
Lentivirus vector construction and transduction. First, we amplified Gluc by PCR using Accuprime Pfx DNA polymerase (Life Technologies) from CSCW-Gluc-IRES-CFP 6 with specific primers that incorporate an XbaI site downstream of the Gluc cDNA (Forward primer: 59-GCGTGTACGGTGGGAGGTCT-39, reverse primer: 59-TCTCGAGTAGAGATCTGTCACCACCGGCCCCCTT-39). The reverse primer also covers the original stop-codon that is thereby removed. The Gluc cDNA, now containing a unique XbaI site, was ligated back into the CSCW-Gluc-IRES-CFP vector with T4 DNA ligase (Life Technologies), after removal of the wild-type Gluc using NheI and XhoI (Life Technologies). Plasmid DNA was transformed in XL-10 Gold ultracompetent cells (Agilent Technologies), cultured overnight in LB agar containing 50 mg/ml Ampicillin. We isolated DNA using a DNA plasmid mini kit (Qiagen) and verified successful transformation by XbaI restriction analysis. The Gluc construct was then digested with XbaI and XhoI to insert the different epitope tags. The epitope tags were designed with an XbaI site upstream, a stop codon and XhoI site downstream. A total of 20 mM of both single strand oligonucleotides of the acquired tag DNA (Life Technologies, see Table S1 for sequences) was annealed in annealing buffer (100 mM Tris-HCl pH 7.5, 1 M NaCl and 10 mM EDTA) by heating to 65uC for 10 minutes and slow cooling to room temperature. The epitope tag was then inserted into the vector using T4 DNA ligase and transformed in XL-10 Gold ultracompetent cells. Bacteria were cultured and DNA was isolated. We verified the Gluc tag constructs by sequencing using BigDye Terminator v3.1 Cycle Sequencing kit (Life Technologies, primer: 59-GCCAACGTGCAGTGTTC-39). The Gluc tag construct was co-transfected with a third generation lentiviral packaging mix (pMDLg/pRRE, pRSV-Rev and pMD2.G, Addgene) in HEK293T cells using Lipofectamine 2000 (Life Technologies). Virus was harvested two and three days after transfection and cell debris was spun down for five minutes at 1,000 3 g. U87 cells were transduced overnight with lentivirus using a multiplicity of infection of 100 transducing units per cell in the presence of 8 mg/ml polybrene in standard culture conditions. www.nature.com/scientificreports SCIENTIFIC REPORTS | 3 : 1046 | DOI: 10.1038/srep01046
Fluorescence microscopy. Successful transduction was verified by visualizing CFP (co-expressed with the Gluc tag construct) and mCherry fluorescent protein (coexpressed with Fluc) using fluorescent microscopy (Leica).
Immunostaining and antibodies. For in vitro immunostaining, cells were fixed in 3.7% formaldehyde for 20 minutes, washed with PBS and permeabilized with PBS containing 0.1% Triton X-100. Cells were then washed three times in PBS containing 5% FBS and blocked with PBS containing 5% FBS. Primary mouse-anti-tag monoclonal antibody (10 mg/ml in 100 ml of PBS, Table S1 ) was added and incubated for one hour at room temperature. Cells were washed again and incubated with 15100 goat-anti-mouse horseradish peroxidase (HRP) conjugate (Dako) for one hour. After washing, cells were stained with DAB1 (Life Technologies). For mouse tissue staining, tumors were removed and embedded in paraffin. Microtome sections of 5 micron on glass slides were deparaffinized in xylene and rehydrated in ethanol series of 100%, 96%, and 70% ethanol. Endogenous peroxide was blocked with 0.3% H 2 O 2 in methanol for 30 minutes. After rinsing with water, antigens were retrieved with citrate buffer (pH 6) with 0.05% Tween 20 using a microwave (Bosch, five minutes 900 watt, 10 minutes 360 watt). After slowly cooling, tissues were washed three times with PBS and incubated with primary antibody (10 mg/ml), for one hour at room temperature. After washing three times again, tissues were incubated with REAL Envision Rabbit anti-mouse (Dako and REAL DAB1 stained (Dako). Tissue sections were dehydrated with ethanol series as before and fixed in xylene. Cells and sections were imaged and photographed by light microscopy (Leica).
Western blot. U87-FM-Gluc tag -CFP cells were lysed in RIPA buffer and mixed with Laemli buffer containing b-mecaptoethanol (80 ml/ml). The samples were separated using a 10% SDS-PAGE gel and the XCell-II blot module (Invitrogen). Primary antibodies (Table S1 ) were used in a 153,000 dilutions and goat-anti-mouse HRP immunoglobuline (Dako) secondary antibody was used in a 152,000 dilution. Incubation times were 1 hour at room temperature.
RT-PCR. U87-FM-Gluc tag -CFP RNA was isolated using Trizol (Invitrogen) according to manufacturer's guidelines. cDNA was generated using Omniscript RT kit (Qiagen) and PCR was performed in triplo using FastStart SYBR Green Master (Rox) mix (Roche). As a forward primer we used 59-GCCAACGTGCAGTGTTC-'3, which is located in the Gluc gene. We used the tag antisense oligonucleotides as tag specific reverse primers (Table S1 ).
In vitro gluc activity assay. For Gluc tag activity measurement over time, 50,000 cells were plated in a 24-well plate and incubated overnight. A total of 10 ml conditioned medium was harvested from cells and Gluc activity was measured by adding 50 ml (5 mg/ml) coelenterazine (Nanolight Technologies) in PBS and 0.1% Triton X-100). Before addition to the sample, the substrate was incubated at room temperature for 30 minutes for stabilization. Photon counts were determined over 10 seconds in a luminometer (Berthold Technologies). For the measurement of Gluc tag activity with respect to cell number, indicated numbers of cells were plated in a 24-well plate and incubated overnight. Gluc tag activity in medium was determined as described above.
Gluc tag immunobinding assay. White goat-anti-mouse-coated 96-well plates (Thermo Scientific) were washed three times with PBS containing 0.05% Tween 20 and incubated with 50 ml (10 mg/ml) of each of the mouse monoclonal antibody directed against the specific epitope tags (Table S1 ). Incubation time was two hours while centrifuging at 500 3 g at 4uC. Wells were washed and blocked three times with PBS containing 5% FBS and 0.05% Tween 20 on a plate shaker at 65-75 rpm. A total of 30 ml of Gluc tag conditioned medium or Gluc tag mouse blood was added to the well and incubated for two hours at room temperature on a microplate shaker at 65-75 rpm. Wells were washed five times for five minutes on a plate shaker at 65-75 rpm. A total of 50 ml Gluc substrate (5 mg/ml coelenterazine in PBS and 0.1% Triton X-100) was added to the well and photon counts were determined in a microplate luminometer (Tecan) at 0.1 second per well. For the comparison of the bound Gluc to the total Gluc activity, aliquots of conditioned medium or 5 ml mouse blood were transferred to a white 96-wells microplate and assayed using 50 ml (5 mg/ml) coelenterazine in PBS and 0.1% Triton X-100.
In vivo experiments. All in vivo experiments were subject to ethical committee approval and are in accordance with VU University Medical Center and national regulations. For subcutaneous tumor xenograft model, six weeks old athymic Nude-Foxn1 nu mice (Harlan) were implanted with 5 3 10 5 U87-FM-Gluc tag -CFP cells in 50 ml DMEM and 50 ml Matrigel (BD Biosciences). For intracranial tumor implantation, a stereotactic frame (Harvard Biosciences) was used to inject cells vertically into the right hemisphere. General anesthesia was induced by subcutaneous injection of buprenorphine hydrochloride (0.1 mg/kg). The mice were further anesthetized with oxygen containing 2.5% isofluorane. After skin incision, lidocaine drops (5 mg/ml in PBS) were administered topically. A small drill was used to drill a hole into the skull. Coordinates used for injection were X 5 0.5 mm, Y 5 2 mm, Z 5 22 mm from the bregma. A total of 2 3 10 5 cells in 5 ml of DMEM was injected vertically. On indicated days after injection, tumor size was monitored using a calliper (for subcutaneous) and bioluminescence in vivo Fluc imaging, by injecting D -luciferin (100 mg/kg) intraperitoneally. Imaging was performed with an IVIS CCD camera and analyzed with Living Image software (Caliper Life Sciences). We collected 300 ml mouse blood aliquots from the tail vein in Microvette CB300 EDTA capillary tubes (Sarstedt) for ex vivo whole Gluc measurements and Gluc immunobinding assays.
